<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01057615</url>
  </required_header>
  <id_info>
    <org_study_id>0910000751</org_study_id>
    <nct_id>NCT01057615</nct_id>
  </id_info>
  <brief_title>Effect of Fish Oil and Vitamin C on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma</brief_title>
  <official_title>Comparative and Additive Effects of Fish Oil and Ascorbic Acid Supplementation on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Combining fish oil and vitamin C supplementation will provide a greater anti-inflammatory
      effect against developing exercise-induced bronchoconstriction (EIB) than either nutritional
      supplement alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to extend previous findings that nutritional supplementation or
      dietary modification can ameliorate exercise-induced bronchoconstriction. It has been shown
      in separate studies that fish oil and ascorbic acid (vitamin C) individually protect against
      EIB by improving pulmonary function and reducing airway inflammation. The main aim of this
      study is to determine the comparative and additive effects of fish oil and ascorbic acid
      supplementation on EIB and airway inflammation in asthmatic individuals.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pulmonary Function</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exhaled nitric oxide to measure airway inflammation</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Active Fish Oil + Vitamin C Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fifteen subjects will take 10 active fish oil capsules per day and 2 vitamin C placebo capsules per day for 3 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fish Oil Placebo + Active Vitamin C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fifteen subjects will take 10 fish oil placebo capsules per day and 2 active vitamin C capsules per day for 3 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Fish Oil + Active Vitamin C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Following a 2-week washout period, all subjects from the other two arms (n=30) will take 10 active fish oil capsules per day and 2 active vitamin C capsules per day for 3 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fish Oil</intervention_name>
    <description>10 fish oil (3.2g EPA + 2.0g DHA) capsules per day for 3 weeks</description>
    <arm_group_label>Active Fish Oil + Vitamin C Placebo</arm_group_label>
    <arm_group_label>Active Fish Oil + Active Vitamin C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ascorbic Acid</intervention_name>
    <description>2 pharmaceutical grade ascorbic acid (1500mg) capsules per day for 3 weeks</description>
    <arm_group_label>Fish Oil Placebo + Active Vitamin C</arm_group_label>
    <arm_group_label>Active Fish Oil + Active Vitamin C</arm_group_label>
    <other_name>Vitamin C</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fish Oil Placebo</intervention_name>
    <description>10 placebo fish oil (soy bean oil) capsules per day for 3 weeks</description>
    <arm_group_label>Fish Oil Placebo + Active Vitamin C</arm_group_label>
    <other_name>Soy Bean Oil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ascorbic Acid Placebo</intervention_name>
    <description>2 placebo ascorbic acid (sucrose) capsules per day for 3 weeks</description>
    <arm_group_label>Active Fish Oil + Vitamin C Placebo</arm_group_label>
    <other_name>Table Sugar</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of asthma, based on medication use as well as history and symptoms as
             outlined in the NHLBI Guidelines for the Diagnosis and Management of Asthma

          -  Diagnosis of EIB, based on â‰¥10% fall in post-challenge FEV1, a measure of lung
             function, after dry air eucapnic voluntary hyperventilation (EVH), a simulated
             exercise challenge

          -  Not currently taking asthma maintenance medication or physician approval to
             discontinue current asthma medication for the duration of the study

          -  Not currently taking any fish oil or ascorbic acid supplements above the level
             recommended for adequate intake (if currently taking supplements, can participate if
             the subject stops taking the supplements for 2 weeks before starting the study and
             throughout the study)

          -  Agree to limit fish consumption to 1 fish meal per week throughout the study

          -  Agree to avoid vitamin C-rich foods throughout the study

        Exclusion Criteria:

          -  Resting FEV1 (the amount of air blown out in the first second of a forced exhalation)
             &lt;60% of predicted when off medication

          -  Pregnancy

          -  History of cardiovascular disease, including hyperlipidemia (high cholesterol) and
             hypertension (high blood pressure)

          -  History of bleeding disorders or delayed clotting time

          -  History of diabetes

          -  History of seizures

          -  Allergy to fish oil or ascorbic acid (vitamin C)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy D Mickleborough, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Bloomington</city>
        <state>Indiana</state>
        <zip>47405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mickleborough TD, Murray RL, Ionescu AA, Lindley MR. Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med. 2003 Nov 15;168(10):1181-9. Epub 2003 Aug 6.</citation>
    <PMID>12904324</PMID>
  </reference>
  <reference>
    <citation>Mickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest. 2006 Jan;129(1):39-49.</citation>
    <PMID>16424411</PMID>
  </reference>
  <reference>
    <citation>Tecklenburg SL, Mickleborough TD, Fly AD, Bai Y, Stager JM. Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma. Respir Med. 2007 Aug;101(8):1770-8. Epub 2007 Apr 5.</citation>
    <PMID>17412579</PMID>
  </reference>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2010</study_first_submitted>
  <study_first_submitted_qc>January 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2010</study_first_posted>
  <last_update_submitted>January 28, 2011</last_update_submitted>
  <last_update_submitted_qc>January 28, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2011</last_update_posted>
  <responsible_party>
    <name_title>Timothy Mickleborough, PhD / Associate Professor</name_title>
    <organization>Indiana University</organization>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Exercise-Induced Bronchoconstriction</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Airway</keyword>
  <keyword>Fish Oil</keyword>
  <keyword>Ascorbic Acid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

